Authors: SCHELLENBERG R SCHWARZ A NIEDERBERGER U BOLSCHE F GERBER WD SCHINDLER M WEDEKIND W SOYKA D

Citation: R. Schellenberg et al., LONG-TIME EFFICACY OF CYCLANDELATE AND PR OPRANOLOL IN PROPHYLAXIS OFMIGRAINE FOLLOWING 4 MONTHS OF TREATMENT, Nervenheilkunde, 16(3), 1997, pp. 183-187

Authors: SCHELLENBERG R TODOROVA A WEDEKIND W SCHOBER F DIMPFEL W

Citation: R. Schellenberg et al., PATHOPHYSIOLOGY AND PSYCHOPHARMACOLOGY OF DEMENTIA - A NEW STUDY DESIGN .2. CYCLANDELATE TREATMENT - A PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL-TRIAL, Neuropsychobiology, 35(3), 1997, pp. 132-142

Authors: DIENER HC FOH M IACCARINO C WESSELY P ISLER H STRENGE H FISCHER M WEDEKIND W TANERI Z

Citation: Hc. Diener et al., CYCLANDELATE IN THE PROPHYLAXIS OF MIGRAINE - A RANDOMIZED, PARALLEL,DOUBLE-BLIND-STUDY IN COMPARISON WITH PLACEBO AND PROPRANOLOL, Cephalalgia, 16(6), 1996, pp. 441-447

Authors: DIMPFEL W SCHOBER F WEDEKIND W KLEINBLOESEM C COORS C

Citation: W. Dimpfel et al., EVIDENCE OF PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS BY MEANS OFPHARMACO-EEG IN HEALTHY-VOLUNTEERS FOLLOWING ADMINISTRATION OF CYCLANDELATE, Arzneimittel-Forschung, 44-2(9), 1994, pp. 999-1004